SCHEMBL8206962

SCHEMBL8206962

c1ccc2c(C3CC4CCC(C3)N4)n[nH]c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.49
HTR2A P28223 1/20 0.49
KDM4E B2RXH2 3/20 0.42
GAA P10253 2/20 0.42
PDPK1 O15530 1/20 0.42
CYP3A4 P08684 1/20 0.42
SLC6A4 P31645 5/20 0.40
SLC6A2 P23975 3/20 0.40
SLC6A3 Q01959 2/20 0.40
ALDH1A1 P00352 2/20 0.40
IDO1 P14902 2/20 0.40
ALPL P05186 1/20 0.40
HPGD P15428 1/20 0.40
TTK P33981 1/20 0.40
MAPK10 P53779 1/20 0.40
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
CYP1A2 P05177 1/20 0.37
CHRNA7 P36544 1/20 0.36
CNR1 P21554 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL9429160 0.87 HTR2A (0.42) KCNH2HTR2AKDM4ESLC6A4SLC6A2
Fumaric Acid SCHEMBL9429150 0.87 HTR2A (0.42) KCNH2HTR2AKDM4ESLC6A4SLC6A2
SCHEMBL3057752 0.83 KDM4E (0.50) HTR2AKDM4EGAAPDPK1CYP3A4
SCHEMBL4004747 0.80 RAB9A (0.48) HTR2AKDM4EGAAPDPK1CYP3A4
SCHEMBL15485748 0.80 KDM4E (0.47) HTR2AKDM4EGAAPDPK1CYP3A4
SCHEMBL8209600 0.79 MAP2K4 (0.43) HTR2ASLC6A4SLC6A2SLC6A3
Hydrochloric Acid SCHEMBL9429130 0.78 MAP2K4 (0.42) HTR2ASLC6A4SLC6A2SLC6A3
SCHEMBL8206871 0.77 HTR2A (0.43) KCNH2HTR2ACYP3A4SLC6A4SLC6A2
SCHEMBL29869220 0.77 HTR2C (0.50) KCNH2HTR2AKDM4EGAAPDPK1
SCHEMBL1545976 0.77 HTR2C (0.50) KCNH2HTR2AKDM4EGAAPDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0984965-A1 8-AZABICYCLO(3,2,1)OCT-2-ENE AND OCTANE DERIVATIVES AS CHOLINERGIC LIGANDS AT NICOTINIC ACH RECEPTORS NEUROSEARCH A/S (DK) 2000-03-15 EP claimed
WO-1998054181-A1 8-AZABICYCLO(3,2,1)OCT-2-ENE AND OCTANE DERIVATIVES AS CHOLINERGIC LIGANDS AT NICOTINIC ACH RECEPTORS NEUROSEARCH A/S (DK) 1998-12-03 WO claimed
US-5334599-A Heteroaryl-8-azabicyclo[3,2,1]octanes as antipsychotic agents, 5-HT3 receptor antagonists and inhibitors of the reuptake of serotonin HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1994-08-02 US claimed
EP-0498331-B1 N-(aryloxyalkyl)heteroaryl-8-azabicyclo(3.2.1)octanes, intermediates and a process for the preparation thereof and their use as medicaments HOECHST ROUSSEL PHARMA (US) 1996-05-22 EP disclosed
US-5340936-A Antipsychotic agents HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1994-08-23 US disclosed
US-5334599-A Heteroaryl-8-azabicyclo[3,2,1]octanes as antipsychotic agents, 5-HT3 receptor antagonists and inhibitors of the reuptake of serotonin HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1994-08-02 US disclosed
US-5234931-A Anxiolytic agents; antdepressants; schizophrenia; drug abuse; medical diagnosis HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-08-10 US disclosed
EP-0498331-A1 N-(aryloxyalkyl)heteroaryl-8-azabicyclo(3.2.1)octanes, intermediates and a process for the preparation thereof and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1992-08-12 EP disclosed